Latest Shareholder Value News

Page 192 of 219
Black Cat Syndicate has restarted underground drilling at its Paulsens Gold Operation, targeting resource expansion and mine life extension with results expected from March 2025.
Maxwell Dee
Maxwell Dee
13 Feb 2025
Origin Energy reported a robust half-year performance with statutory profit rising to $1.017 billion and an increased fully franked interim dividend, driven by strong Integrated Gas earnings despite softer Energy Markets and Octopus Energy results.
Maxwell Dee
Maxwell Dee
13 Feb 2025
Origin Energy has announced a fully franked ordinary dividend of AUD 0.30 per share for the six months ending December 2024, signaling steady shareholder returns.
Maxwell Dee
Maxwell Dee
13 Feb 2025
Treasury Wine Estates has announced a 20-cent per share dividend for the half-year ending December 2024, accompanied by a fully franked component and an active Dividend Reinvestment Plan.
Victor Sage
Victor Sage
13 Feb 2025
Insurance Australia Group Limited (IAG) has announced an ordinary dividend of AUD 0.12 per share, partially franked at 60%, with key dates set for February and March 2025.
Claire Turing
Claire Turing
13 Feb 2025
Sandon Capital Investments Limited reported a robust half-year performance with double-digit growth in revenue and profit, alongside a strategic shift to quarterly dividend payments starting March 2025.
Claire Turing
Claire Turing
12 Feb 2025
LCL Resources has cleared major hurdles in its sale of Colombian gold assets to Tiger Gold Corp, with shareholder approval the final step before a $1 million payment is triggered.
Maxwell Dee
Maxwell Dee
12 Feb 2025
Vanadium Resources Limited has raised A$783,000 through a convertible note issue to fund working capital and progress strategic equity partnerships for its Steelpoortdrift Vanadium Project.
Maxwell Dee
Maxwell Dee
12 Feb 2025
Forrestania Resources has secured $360,000 through a non-brokered placement, attracting a new major shareholder and setting the stage for expanded gold exploration at its Bonnie Vale project.
Maxwell Dee
Maxwell Dee
12 Feb 2025
Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.
Victor Sage
Victor Sage
12 Feb 2025
Brightstar Resources has entered a strategic earn-in agreement with Cazaly Resources, allowing Cazaly to earn up to 80% of the Goongarrie Gold Project by funding $3 million in exploration. This move streamlines Brightstar’s portfolio, enabling a sharper focus on advancing key development projects.
Maxwell Dee
Maxwell Dee
12 Feb 2025
Cazaly Resources has inked a binding joint venture with Brightstar Resources to earn up to 80% of the Goongarrie Gold Project in Western Australia, targeting multiple high-potential gold zones with a $3 million exploration commitment.
Maxwell Dee
Maxwell Dee
12 Feb 2025